Eyenuk, Medical Device News Magazine

We use cookies to improve the performance of our website, to analyze the traffic to our website, and to personalize your experience. If you continue to use this website without changing your settings, you agree that cookies may be placed on your device in accordance with our cookie policy. For detailed guidance on how to control or disable cookies, we recommend you visit https://www.aboutcookies.org. Some features of our website and application may not function properly if you change or disable Internet cookies. To find our more about our cookie policy on this website, see our Privacy Policy.

Eyenuk

Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy

4/25/19: Results From Prospective, Multi-Center, Pivotal Clinical Trial on the EyeArt® AI Eye Screening System to be Announced by Eyenuk Inc. at the ARVO Conference

Eyenuk, Inc. Receives Health Canada Approval for EyeArt™, an AI-enabled Cloud-based Automated Diabetic Retinopathy Screening Software